TrialCancer immunology, immunotherapy : CII2020

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.

Masanori Noguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.